Posted in News Research Technology

A pinprick to pinpoint hearing loss

Hearing loss is actually a pretty vague diagnosis.  It’s an umbrella label that covers a multitude of underlying conditions which cause hearing to fade.  But…

Continue Reading A pinprick to pinpoint hearing loss
Posted in FX-322 News

The end of the road for FX-322

Disappointing news from Frequency Therapeutics.  The company announced that its giving up on FX-322, a drug that it hoped could treat Sensorineural Hearing Loss and…

Continue Reading The end of the road for FX-322
Scientist Graham Casey at work in the Frequency Therapeutics lab
Posted in News Research

A new drug candidate offers new hope

  Frequency Therapeutics is one of only a handful of companies around the world that are working to develop a drug to restore lost hearing. …

Continue Reading A new drug candidate offers new hope
Posted in CGF166 Research

Novartis suspends CGF166 trials

It held the promise of restoring lost hearing by prompting dead hair cells in the cochlea to revive and regrow but that hope has now…

Continue Reading Novartis suspends CGF166 trials